Corporate Charter

About IXFY: A Trusted Platform for Independent Reporting & Intelligence

Delivering independent reporting, technology analysis, and deep investigations across global markets, biotechnology, industry developments, and society.

200+

In-Depth Publications

Curated intelligence and investigative articles published across science, biotechnology, industrial compliance, and global technology.

100%

Original & Fact-Checked

Every piece undergoes rigorous editorial verification against primary scientific papers, regulatory filings, and audited institutional data.

Global•

Editorial Desks

A dedicated network of specialized contributors covering biotechnology, international compliance, and emerging technologies.

IXFY: Dedicated to Journalistic Excellence & Analytical Clarity

IXFY is a digital intelligence and reporting platform committed to delivering context-rich perspectives on the technologies, discoveries, and policies transforming the modern world.

From advancements in life sciences and biotechnology to industrial screening, AI infrastructure, and global market dynamics, our journalists and researchers bring forward verified facts and structured insights.

At IXFY, we prioritize accuracy over speed. In an era saturated with synthetic noise, we believe verified human insight and transparent sourcing are essential pillars of credible journalism.

Informed minds shape tomorrow.
Welcome to IXFY.

Our Editorial Desks & Contributors

The specialized writers and editors shaping IXFY's daily coverage.

Strategic Sectoral Coverage

Our beat reporters focus on pivotal industrial transitions where technology, policy, and capital converge.

Deep Tech & Applied AI

Enterprise artificial intelligence, semiconductor foundry advances, cloud supercomputing, autonomous robotics, and computational infrastructure driving global automation.

Biotechnology & Life Sciences

Rigorous scientific journalism covering Phase I-III clinical trial readouts, oncology pipelines, cellular therapeutics, genetic engineering, and health authority decisions.

Venture Capital & Private Markets

Tracking global venture financing rounds, unicorn valuations, cross-border corporate mergers and acquisitions (M&A), and public equity listings across tech and industrial sectors.

Global Regulatory & Compliance

Investigating antitrust investigations, EU green directives, microplastic prohibitions, cross-border data sovereignty, and SEC/ESMA financial transparency rules.

International Bureaus & Newsroom Presence

Operating continuously across major financial and technological time zones.

Europe HQ

London Bureau

Fleet Street & Canary Wharf Media Quarter
London, United Kingdom

london@ixfy.net

Americas

New York Bureau

Midtown Manhattan Media Hub
New York, NY, United States

newyork@ixfy.net

Continental Europe

Frankfurt Bureau

Bankenviertel Financial Corridor
Frankfurt am Main, Germany

frankfurt@ixfy.net

Asia-Pacific

Singapore Bureau

Marina Bay Financial Centre
Singapore

singapore@ixfy.net

Impartial and Independent

IXFY operates free from commercial or political interference, ensuring that every published piece is rooted in verified sources, audited disclosures, and empirical evidence.

Context Over Sensationalism

We look beyond short-term market noise to deliver deep structural context, exploring the macroeconomic, regulatory, and technical consequences of modern breakthroughs.

Rigorous Fact-Checking Charter

Every data point, corporate metric, and clinical trial endpoint is audited against primary academic databases, patent registers, and official regulatory filings before release.